StockData
DNA X, Inc. logo

DNA X, Inc. (SONM) stock

SONMNasdaqTelephone & Telegraph ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$2.38+0.10 (+4.39%)

Close on Nov 12, 2026Market cap $3.54MP/E –Yield –

DNA X operating margin

Operating margin is operating income as a percentage of revenue.

DNA X's operating margin for the twelve months ending Sep 30, 2025 was 3.6%. For fiscal 2024 it was -5.3%, against 0.5% the year before. The highest annual figure on record is 4.0% in fiscal 2018.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2024Dec 31, 2024-5.3%−5.9
FY2023Dec 31, 20230.5%+21.0
FY2022Dec 31, 2022-20.5%+49.2
FY2021Dec 31, 2021-69.6%−23.9
FY2020Dec 31, 2020-45.7%−26.5
FY2019Dec 31, 2019-19.3%−23.2
FY2018Dec 31, 20184.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2025Sep 30, 2025-24.5%−8.7
Q2 FY2025Jun 30, 2025-13.1%+43.0
Q1 FY2025Mar 31, 2025-5.2%+10.8
Q4 FY2024Dec 31, 202456.3%+65.6
Q3 FY2024Sep 30, 2024-15.8%−18.3
Q2 FY2024Jun 30, 2024-56.2%−59.0
Q1 FY2024Mar 31, 2024-16.0%−17.3
Q4 FY2023Dec 31, 2023-9.3%−5.0
Q3 FY2023Sep 30, 20232.5%+11.9
Q2 FY2023Jun 30, 20232.8%+38.1
Q1 FY2023Mar 31, 20231.3%+54.7
Q4 FY2022Dec 31, 2022-4.4%+69.3
Q3 FY2022Sep 30, 2022-9.4%+64.8
Q2 FY2022Jun 30, 2022-35.3%+19.0
Q1 FY2022Mar 31, 2022-53.4%+20.5
Q4 FY2021Dec 31, 2021-73.7%−26.6
Q3 FY2021Sep 30, 2021-74.2%−2.9
Q2 FY2021Jun 30, 2021-54.3%−11.2
Q1 FY2021Mar 31, 2021-73.9%−52.2
Q4 FY2020Dec 31, 2020-47.1%−36.6
Q1 FY2020Mar 31, 2020-71.3%−55.7
Q4 FY2019Dec 31, 2019-43.1%−55.0
Q3 FY2019Sep 30, 2019-21.7%−30.0
Q2 FY2019Jun 30, 2019-10.5%−12.4
Q1 FY2019Mar 31, 2019-15.6%+6.4
Q4 FY2018Dec 31, 201811.9%–
Q3 FY2018Sep 30, 20188.3%–
Q2 FY2018Jun 30, 20181.9%–
Q1 FY2018Mar 31, 2018-22.1%–

More DNA X figures

See a number that looks wrong?